🚀 VC round data is live in beta, check it out!
PMV Pharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for PMV Pharma and similar public comparables like XBiotech, BeyondSpring, BGM Group, IBT and more.
PMV Pharma Overview
About PMV Pharma
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
Founded
2013
HQ
Employees
47
Website
Sectors
Financials (LTM)
Market Cap
$70M
PMV Pharma Financials
PMV Pharma reported last 12-month revenue of —.
In the same LTM period, PMV Pharma generated had net loss of ($82M).
Revenue (LTM)
PMV Pharma P&L
In the most recent fiscal year, PMV Pharma reported revenue of — and EBITDA of ($86M).
PMV Pharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA | — | XXX | ($86M) | XXX | XXX | XXX |
| Net Profit | ($82M) | XXX | ($78M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
PMV Pharma Stock Performance
PMV Pharma has current market cap of $70M.
Market Cap Evolution
PMV Pharma's stock price is $1.32.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $70M | 0.0% | XXX | XXX | XXX | $-1.46 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPMV Pharma Valuation Multiples
PMV Pharma trades at 0.5x EV/EBITDA.
EV / Revenue (LTM)
PMV Pharma Financial Valuation Multiples
As of April 11, 2026, PMV Pharma has market cap of $70M.
Equity research analysts estimate PMV Pharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
PMV Pharma has a P/E ratio of (0.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $70M | XXX | $70M | XXX | XXX | XXX |
| EV (current) | ($42M) | XXX | ($42M) | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBIT | 0.5x | XXX | 0.5x | XXX | XXX | XXX |
| P/E | (0.9x) | XXX | (0.9x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 0.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PMV Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
PMV Pharma Margins & Growth Rates
PMV Pharma's revenue in the last fiscal year grew by —.
PMV Pharma's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.8M for the same period.
PMV Pharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 2% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $1.8M | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
PMV Pharma Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| XBiotech | XXX | XXX | XXX | XXX | XXX | XXX |
| BeyondSpring | XXX | XXX | XXX | XXX | XXX | XXX |
| BGM Group | XXX | XXX | XXX | XXX | XXX | XXX |
| IBT | XXX | XXX | XXX | XXX | XXX | XXX |
| InflaRx | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
PMV Pharma M&A Activity
PMV Pharma acquired XXX companies to date.
Last acquisition by PMV Pharma was on XXXXXXXX, XXXXX. PMV Pharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by PMV Pharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPMV Pharma Investment Activity
PMV Pharma invested in XXX companies to date.
PMV Pharma made its latest investment on XXXXXXXX, XXXXX. PMV Pharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by PMV Pharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PMV Pharma
| When was PMV Pharma founded? | PMV Pharma was founded in 2013. |
| Where is PMV Pharma headquartered? | PMV Pharma is headquartered in United States. |
| How many employees does PMV Pharma have? | As of today, PMV Pharma has over 47 employees. |
| Who is the CEO of PMV Pharma? | PMV Pharma's CEO is David H. Mack. |
| Is PMV Pharma publicly listed? | Yes, PMV Pharma is a public company listed on Nasdaq. |
| What is the stock symbol of PMV Pharma? | PMV Pharma trades under PMVP ticker. |
| When did PMV Pharma go public? | PMV Pharma went public in 2020. |
| Who are competitors of PMV Pharma? | PMV Pharma main competitors are XBiotech, BeyondSpring, BGM Group, IBT. |
| What is the current market cap of PMV Pharma? | PMV Pharma's current market cap is $70M. |
| Is PMV Pharma profitable? | No, PMV Pharma is not profitable. |
| What is the current net income of PMV Pharma? | PMV Pharma's last 12 months net income is ($82M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.